Literature DB >> 20031752

Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry.

Bina Ahmed1, Winthrop D Piper, David Malenka, Peter VerLee, John Robb, Thomas Ryan, Michael Herne, William Phillips, Harold L Dauerman.   

Abstract

BACKGROUND: Women are at a higher risk for bleeding/vascular complications (VC) related to cardiovascular procedures. Although the overall incidence of percutaneous coronary intervention (PCI)-related bleeding/VC has declined, the impact of this decline, specifically in women, is unknown. METHODS AND
RESULTS: We studied 13 653 female and 32 334 male consecutive cases, from 2002 to 2007, in the Northern New England PCI Registry. We sought to (1) compare absolute rates of bleeding/VC in women and men over time, (2) define predictors of bleeding/VC in women and men undergoing PCI, and (3) trend the impact of female gender in predicting bleeding/VC over time. Bleeding/VC was defined as any access-site vessel injury requiring surgical intervention or bleeding requiring transfusion. The overall risk of bleeding/VC was significantly higher in women versus men (4.5+/-1.3% versus 1.6+/-0.5%; P<0.004). Over time, there was a significant (P<0.001) 50% decrease in absolute bleeding/VC rates in both women and men. After adjustment for baseline differences, female gender remained a significant predictor of increased risk in 2007 (odds ratio, 2.6; 95% CI, 1.74 to 3.91). Independent predictors of increased risk of bleeding/VC in women included older age, shock, renal failure, presentation with non-ST-elevation myocardial infraction and larger sheath sizes, whereas the use of fluoroscopy-guided access, closure devices, history of dyslipidemia or prior PCI, and use of bivalirudin were protective.
CONCLUSIONS: Women undergoing PCI have had a significant decline in bleeding/VC rates during the last 6 years. Despite the improvement in procedural safety, female gender continues to be associated with a >2-fold risk of bleeding/VC compared with men.

Entities:  

Mesh:

Year:  2009        PMID: 20031752     DOI: 10.1161/CIRCINTERVENTIONS.109.860494

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  40 in total

1.  Critical lower limb ischemia from an embolized Angio-Seal closure device.

Authors:  Chris Cianci; Robert C Kowal; Georges Feghali; Stephen Hohmann; Robert C Stoler; James W Choi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-10

Review 2.  Vascular Access-Related Complications in Women: Temporal Trends, Emerging Data, and the Current State of Interventional Cardiology Practice.

Authors:  Yohan Chacko; Rushi V Parikh; Jennifer A Tremmel
Journal:  Curr Atheroscler Rep       Date:  2018-06-08       Impact factor: 5.113

3.  In-Hospital and One-Year Clinical Outcome of Percutaneous Coronary Intervention in a Tertiary Hospital in Oman: Oman PCI Registry.

Authors:  Prashanth Panduranga; Majdah Al-Rashidi; Fatma Al-Hajri
Journal:  Oman Med J       Date:  2017-01

4.  Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.

Authors:  Neil J Wimmer; Eric A Secemsky; Laura Mauri; Matthew T Roe; Paramita Saha-Chaudhuri; David Dai; James M McCabe; Frederic S Resnic; Hitinder S Gurm; Robert W Yeh
Journal:  Circ Cardiovasc Interv       Date:  2016-04       Impact factor: 6.546

Review 5.  Achieving safe femoral arterial access.

Authors:  Michael S Lee; Jeremy Kong
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

Review 6.  Role of Gender in Dual Antiplatelet Therapy After Acute Coronary Syndrome.

Authors:  Jaya Mallidi; Kusum Lata
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

7.  TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.

Authors:  Connie N Hess; Sunil V Rao; David F Kong; Julie M Miller; Kevin J Anstrom; Olivier F Bertrand; Jean-Philippe Collet; Mark B Effron; Benjamin C Eloff; Emmanuel O Fadiran; Andrew Farb; Ian C Gilchrist; David R Holmes; Alice K Jacobs; Prashant Kaul; L Kristin Newby; David R Rutledge; Dale R Tavris; Thomas T Tsai; Roseann M White; Eric D Peterson; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2013-03       Impact factor: 4.749

Review 8.  Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction.

Authors:  Matthew Liakos; Puja B Parikh
Journal:  Curr Cardiol Rep       Date:  2018-06-16       Impact factor: 2.931

Review 9.  Gender and anti-thrombotic therapy: from biology to clinical implications.

Authors:  Rossella Marcucci; Gabriele Cioni; Betti Giusti; Cinzia Fatini; Lorenza Rossi; Maddalena Pazzi; Rosanna Abbate
Journal:  J Cardiovasc Transl Res       Date:  2014-01-28       Impact factor: 4.132

10.  Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry.

Authors:  Stacie L Daugherty; Lauren E Thompson; Sunghee Kim; Sunil V Rao; Sumeet Subherwal; Thomas T Tsai; John C Messenger; Frederick A Masoudi
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.